Mirae Asset Global Investments Co. Ltd. Has $299,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 84.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,278 shares of the exchange traded fund’s stock after selling 18,112 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in SPDR S&P Biotech ETF were worth $299,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of XBI. CWM LLC increased its position in SPDR S&P Biotech ETF by 22.0% in the 3rd quarter. CWM LLC now owns 10,239 shares of the exchange traded fund’s stock worth $1,012,000 after buying an additional 1,849 shares during the period. Creative Planning grew its stake in shares of SPDR S&P Biotech ETF by 15.6% in the third quarter. Creative Planning now owns 29,114 shares of the exchange traded fund’s stock worth $2,876,000 after acquiring an additional 3,920 shares during the last quarter. Swedbank AB bought a new position in SPDR S&P Biotech ETF during the third quarter worth $22,843,000. Vontobel Holding Ltd. raised its stake in SPDR S&P Biotech ETF by 23.2% during the 3rd quarter. Vontobel Holding Ltd. now owns 6,542 shares of the exchange traded fund’s stock valued at $646,000 after purchasing an additional 1,233 shares during the last quarter. Finally, Firethorn Wealth Partners LLC boosted its holdings in SPDR S&P Biotech ETF by 4.2% in the 3rd quarter. Firethorn Wealth Partners LLC now owns 8,078 shares of the exchange traded fund’s stock valued at $798,000 after purchasing an additional 329 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $90.77 on Friday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock has a market cap of $6.92 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a 50-day simple moving average of $91.92 and a 200 day simple moving average of $96.21.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.